Systematic Immune Inflammation and Survival in Patients Receiving ICIs for NSCLC

9 months ago 50

Pretreatment systemic immune-inflammation is associated with survival outcomes in patients with non-small cell lung cancer (NSCLC) who receive immune checkpoint inhibitors.

1. Homepage
2. Lung Cancer
3. Systematic Immune Inflammation and Survival in Patients Receiving ICIs for NSCLC